SCHEMBL13620347

SCHEMBL13620347

O=c1c(Cl)c(O)cnn1O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KAT2B Q92831 3/20 0.36
BRD9 Q9H8M2 2/20 0.36
GABRA1 P14867 1/20 0.35
GABRB2 P47870 1/20 0.35
ALDH1A1 P00352 6/20 0.34
HTT P42858 6/20 0.34
SMN1; SMN2 Q16637 5/20 0.34
NPC1 O15118 4/20 0.34
MITF O75030 2/20 0.34
MAPT P10636 4/20 0.33
KMT2A Q03164 3/20 0.33
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
GAA P10253 2/20 0.32
RAB9A P51151 5/20 0.32
S1PR4 O95977 2/20 0.32
S1PR1 P21453 2/20 0.32
PAX8 Q06710 2/20 0.32
THRB P10828 1/20 0.32
XBP1 P17861 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12160455 0.81 KAT2B (0.56) KAT2BBRD9ALDH1A1MAPTGAA
SCHEMBL14385184 0.80 HTT (0.50) ALDH1A1HTTSMN1; SMN2NPC1MITF
SCHEMBL13620346 0.78 GRIA1 (0.39) KAT2BBRD9GABRA1GABRB2ALDH1A1
SCHEMBL1627207 0.76 SMN1; SMN2 (0.46) ALDH1A1HTTSMN1; SMN2NPC1MITF
SCHEMBL10366081 0.76 BPTF (0.46) KAT2BBRD9ALDH1A1HTTSMN1; SMN2
SCHEMBL9828927 0.76 GAA (0.57) KAT2BALDH1A1HTTSMN1; SMN2NPC1
SCHEMBL2326495 0.72 HTR2A (0.41) KAT2BALDH1A1HTTSMN1; SMN2NPC1
SCHEMBL2323909 0.71 GAA (0.41) ALDH1A1HTTSMN1; SMN2NPC1MITF
SCHEMBL21557032 0.71 SMN1; SMN2 (0.37) ALDH1A1HTTSMN1; SMN2NPC1MITF
SCHEMBL9664481 0.70 RAB9A (0.54) ALDH1A1HTTSMN1; SMN2NPC1MITF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2123264-A1 Heterocyclic derivatives as abnormal cannabidiols agents for lowering intraocular pressure Allergan, Inc. (US) 2009-11-25 EP disclosed
WO-2007127711-A2 ABNORMAL CANNABIDIOLS AS AGENTS FOR LOWERING INTRAOCULAR PRESSURE ALLERGAN, INC. (US) 2007-11-08 WO disclosed